Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Resolving US Hemp Dilemma Takes Detour As House Starts Farm Bill Re-Authorization Journey

May 28 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Doubts Hemp ‘Derivatives Created From Scratch’ Belong In Lawful Use Pathway

Feb 06 2023

House Draft Farm Bill Narrows Hemp Definition While Industry Juggles States' THC Levels

May 22 2024

Clarifying Marijuana’s Use As Medical Drug In US Won’t Clear Cloud Over Pathway For Hemp’s Use

May 19 2024

Proliferation Of Intoxicating Hemp Ingredients Prompts Request For Federal Regulatory Pathway

Apr 11 2024

CBD Market Provides ‘Enormous Incentive’ For FDA's Regulatory Answer But Decision Remains TBD

Dec 10 2020

Additional Topics

International United States US States Cannabidiol CBD Legislation Politics Advertising, Marketing & Sales Business Strategies Compliance Consumer Commercial Distribution Dietary Supplements E-Commerce Ingredients Manufacturing Policy Regulation Regulatory Retail Enforcement

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window